Evaluate Ovulation and PK of Medroxyprogesterone Acetate Following Dose of TV-46046

Study Title

Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

Teva Identifier

TV46046-WH-10075

ClinicalTrials.gov Identifier

NCT02817464

Study Status

Completed

Trial Condition(s)

Pregnancy | Contraception

Interventions

Drug: TV-46046 - 400 mg/mL | Drug: TV-46046 - 200 mg/mL | Drug: TV-46046 - 300 mg/mL (if warranted)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
female icon for clinical trials

Key Participation Requirements

Gender

Female

Age Range

18 Years to 40 Years

Trial Duration

October 7, 2016 - December 3, 2018

Phase

Phase 1

Study Type

Interventional